1. Home
  2. WY vs HOLX Comparison

WY vs HOLX Comparison

Compare WY & HOLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Weyerhaeuser Company

WY

Weyerhaeuser Company

N/A

Current Price

$23.04

Market Cap

17.4B

Sector

Real Estate

ML Signal

N/A

Logo Hologic Inc.

HOLX

Hologic Inc.

N/A

Current Price

$75.35

Market Cap

16.6B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
WY
HOLX
Founded
1900
1985
Country
United States
United States
Employees
N/A
N/A
Industry
Real Estate Investment Trusts
Medical Electronics
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
17.4B
16.6B
IPO Year
1994
1995

Fundamental Metrics

Financial Performance
Metric
WY
HOLX
Price
$23.04
$75.35
Analyst Decision
Buy
Hold
Analyst Count
7
13
Target Price
$29.00
$77.89
AVG Volume (30 Days)
5.4M
2.2M
Earning Date
04-30-2026
01-01-0001
Dividend Yield
3.62%
N/A
EPS Growth
N/A
N/A
EPS
0.45
0.79
Revenue
$6,905,000,000.00
$4,100,500,000.00
Revenue This Year
$6.13
$4.74
Revenue Next Year
$8.92
$5.03
P/E Ratio
$51.63
$95.46
Revenue Growth
N/A
1.74
52 Week Low
$21.16
$51.90
52 Week High
$30.28
$75.75

Technical Indicators

Market Signals
Indicator
WY
HOLX
Relative Strength Index (RSI) 23.07 50.04
Support Level $22.59 $75.20
Resistance Level $24.03 $75.35
Average True Range (ATR) 0.59 0.19
MACD -0.21 -0.02
Stochastic Oscillator 1.80 19.38

Price Performance

Historical Comparison
WY
HOLX

About WY Weyerhaeuser Company

Weyerhaeuser Co ranks among the world's key forest product companies. Following the 2016 sale of its pulp business to International Paper, Weyerhaeuser operates three business segments: timberlands, wood products, and real estate. Weyerhaeuser is structured as a real estate investment trust and is not required to pay federal income taxes on earnings generated by timber harvest activities. Earnings from its wood products segment are subject to federal income tax. Weyerhaeuser acquired fellow timber REIT Plum Creek in 2016.

About HOLX Hologic Inc.

Hologic manufactures proprietary products for the healthcare needs of women. The company operates in four segments: diagnostics (44% of total sales), breast health (38%), surgical (16%), and skeletal health (2%). While the company traditionally focused on breast health, the acquisition of Gen-Probe put greater emphasis on commercial diagnostics. The United States accounts for the largest portion of the firm's revenue (69%), followed by Europe (20%), Asia (8%), and other international markets (3%). Hologic is headquartered in Bedford, Massachusetts.

Share on Social Networks: